BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

27839

544306

SAILIFE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SAI LIFE SCIENCES LIMITED performance

Today’s low

Today’s high

₹ 694.00 ₹ 719.05
₹ 696.80

52 week low

52 week high

₹ 636.10 ₹ 808.80
₹ 696.80

Open Price

₹ 710.00

Prev. Close

₹ 714.30

Volume (Shares)

112902.00

Total traded value

₹ 786.70

Upper Circuit

₹ 857.15

Lower Circuit

₹ 571.45

info

SAI LIFE SCIENCES LIMITED Share Price Update

As of the latest trading session, SAI LIFE SCIENCES LIMITED share price is currently at ₹ 696.8, which is down by ₹ -17.50 from its previous closing. Today, the stock has fluctuated between ₹ 694.00 and ₹ 719.05. Over the past year, SAI LIFE SCIENCES LIMITED has achieved a return of 0.00 %. In the last month alone, the return has been -5.60 %. Read More...

SAI LIFE SCIENCES LIMITED fundamentals


  • Market cap (Cr)

    1,230.76

  • P/E Ratio (TTM)

    102.61

  • Beta

    1.70

  • Book Value / share

    94.14

  • Return on equity

    9.90%

  • EPS (TTM)

    6.96

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    51.06

info icon alternate text
  • Market cap (Cr)

    1,231.37

  • P/E Ratio (TTM)

    102.61

  • Beta

    1.64

  • Book Value / share

    94.14

  • Return on equity

    9.90%

  • EPS (TTM)

    6.96

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    51.06

info icon alternate text

SAI LIFE SCIENCES LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 428.60
Operating Expense 370.14
Net Profit 51.06
Net Profit Margin (%) 11.91
Earnings Per Share (EPS) 2.74
EBITDA 120.63
Effective Tax Rate (%) 24.82
Particulars SEP 2024 (Values in Cr)
Revenue 381.97
Operating Expense 333.43
Net Profit 43.85
Net Profit Margin (%) 11.47
Earnings Per Share (EPS) 2.32
EBITDA 110.72
Effective Tax Rate (%) 25.04
Particulars JUN 2024 (Values in Cr)
Revenue 264.47
Operating Expense 0.00
Net Profit -11.38
Net Profit Margin (%) -4.30
Earnings Per Share (EPS) 0.00
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 427.54
Operating Expense 0.00
Net Profit 61.50
Net Profit Margin (%) 14.38
Earnings Per Share (EPS) 34.07
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 372.60
Operating Expense 329.08
Net Profit 40.18
Net Profit Margin (%) 10.78
Earnings Per Share (EPS) 22.27
EBITDA 104.11
Effective Tax Rate (%) 25.77
Particulars MAR 2024 (Values in Cr)
Revenue 1418.68
Operating Expense 1319.01
Net Profit 95.23
Net Profit Margin (%) 6.71
Earnings Per Share (EPS) 52.57
EBITDA 315.94
Effective Tax Rate (%) 26.17
Particulars MAR 2023 (Values in Cr)
Revenue 1157.40
Operating Expense 1152.68
Net Profit 24.24
Net Profit Margin (%) 2.09
Earnings Per Share (EPS) 14.26
EBITDA 191.10
Effective Tax Rate (%) 25.84
Particulars MAR 2022 (Values in Cr)
Revenue 841.02
Operating Expense 846.82
Net Profit 15.68
Net Profit Margin (%) 1.86
Earnings Per Share (EPS) 10.12
EBITDA 149.54
Effective Tax Rate (%) 29.84
Particulars MAR 2021 (Values in Cr)
Revenue 751.47
Operating Expense 691.17
Net Profit 65.30
Net Profit Margin (%) 8.68
Earnings Per Share (EPS) 39.11
EBITDA 188.69
Effective Tax Rate (%) 25.43
Particulars MAR 2024 (Values in Cr)
Book Value / Share 551.96
ROE % 8.89
ROCE % 10.46
Total Debt to Total Equity 1.00
EBITDA Margin 21.58
Particulars MAR 2023 (Values in Cr)
Book Value / Share 503.80
ROE % 1.13
ROCE % 5.29
Total Debt to Total Equity 0.95
EBITDA Margin 16.17
Particulars MAR 2022 (Values in Cr)
Book Value / Share 500.21
ROE % -0.58
ROCE % 3.12
Total Debt to Total Equity 0.80
EBITDA Margin 16.45
Particulars MAR 2021 (Values in Cr)
Book Value / Share 494.88
ROE % 7.37
ROCE % 8.55
Total Debt to Total Equity 0.57
EBITDA Margin 25.61
Particulars MAR 2020 (Values in Cr)
Book Value / Share 484.03
ROE % 9.61
ROCE % 11.42
Total Debt to Total Equity 0.38
EBITDA Margin 25.57
Particulars MAR 2024 (Values in Cr)
Book Value / Share 572.37
ROE % 9.90
ROCE % 11.36
Total Debt to Total Equity 0.90
EBITDA Margin 22.37
Particulars MAR 2023 (Values in Cr)
Book Value / Share 517.79
ROE % 2.69
ROCE % 5.96
Total Debt to Total Equity 0.90
EBITDA Margin 16.83
Particulars MAR 2022 (Values in Cr)
Book Value / Share 507.50
ROE % 0.50
ROCE % 3.72
Total Debt to Total Equity 0.79
EBITDA Margin 16.85
Particulars MAR 2021 (Values in Cr)
Book Value / Share 486.92
ROE % 7.86
ROCE % 8.93
Total Debt to Total Equity 0.57
EBITDA Margin 25.48
Particulars MAR 2020 (Values in Cr)
Book Value / Share 484.05
ROE % 10.61
ROCE % 12.57
Total Debt to Total Equity 0.37
EBITDA Margin 25.88
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 158.80
Total Assets 2275.13
Total Liabilities 2275.13
Total Equity 975.14
Share Outstanding 17663034
Price to Book Ratio 0.00
Return on Assets (%) 3.63
Return on Capital (%) 4.91
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 86.33
Total Assets 2186.64
Total Liabilities 2186.64
Total Equity 888.09
Share Outstanding 17622556
Price to Book Ratio 0.00
Return on Assets (%) 0.45
Return on Capital (%) 0.63
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 152.00
Total Assets 2239.92
Total Liabilities 2239.92
Total Equity 1011.19
Share Outstanding 17663034
Price to Book Ratio 0.00
Return on Assets (%) 4.25
Return on Capital (%) 5.53
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 80.01
Total Assets 2130.62
Total Liabilities 2130.62
Total Equity 912.73
Share Outstanding 17622556
Price to Book Ratio 0.00
Return on Assets (%) 1.13
Return on Capital (%) 1.5
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 123.52
Total Assets 2105.89
Total Liabilities 2105.89
Total Equity 891.03
Share Outstanding 17556306
Price to Book Ratio 0.00
Return on Assets (%) 0.74
Return on Capital (%) 0.95
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 70.09
Total Assets 1816.48
Total Liabilities 1816.48
Total Equity 867.51
Share Outstanding 17429579
Price to Book Ratio 0.00
Return on Assets (%) 3.59
Return on Capital (%) 4.34
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 92.96
Total Assets 1389.22
Total Liabilities 1389.22
Total Equity 794.41
Share Outstanding 16382929
Price to Book Ratio 0.00
Return on Assets (%) 5.76
Return on Capital (%) 7.45
Particulars MAR 2024 (Values in Cr)
Net Income 109.23
Cash from Operations 276.96
Cash from Investing -192.38
Cash from Financing -95.29
Net change in Cash -24.59
Free Cash Flow 458.65
Particulars MAR 2023 (Values in Cr)
Net Income 16.40
Cash from Operations 223.48
Cash from Investing -101.78
Cash from Financing -200.64
Net change in Cash -83.02
Free Cash Flow 336.55
Particulars MAR 2022 (Values in Cr)
Net Income 9.69
Cash from Operations 112.98
Cash from Investing -103.71
Cash from Financing 71.92
Net change in Cash 75.15
Free Cash Flow 319.90
Particulars MAR 2021 (Values in Cr)
Net Income 81.91
Cash from Operations -20.93
Cash from Investing -259.89
Cash from Financing 295.49
Net change in Cash -0.77
Free Cash Flow 241.13
Particulars MAR 2020 (Values in Cr)
Net Income 109.08
Cash from Operations 135.13
Cash from Investing -261.69
Cash from Financing -4.06
Net change in Cash -150.25
Free Cash Flow 407.29
Particulars MAR 2024 (Values in Cr)
Net Income 129.00
Cash from Operations 264.13
Cash from Investing -190.05
Cash from Financing -84.63
Net change in Cash -24.03
Free Cash Flow 443.49
Particulars MAR 2023 (Values in Cr)
Net Income 32.68
Cash from Operations 225.55
Cash from Investing -111.22
Cash from Financing -190.04
Net change in Cash -79.79
Free Cash Flow 339.53
Particulars MAR 2022 (Values in Cr)
Net Income 22.35
Cash from Operations 96.48
Cash from Investing -94.63
Cash from Financing 80.95
Net change in Cash 74.69
Free Cash Flow 294.31
Particulars MAR 2021 (Values in Cr)
Net Income 87.58
Cash from Operations -9.23
Cash from Investing -279.45
Cash from Financing 303.57
Net change in Cash -1.81
Free Cash Flow 231.82
Particulars MAR 2020 (Values in Cr)
Net Income 114.08
Cash from Operations 128.13
Cash from Investing -259.40
Cash from Financing -1.40
Net change in Cash -152.04
Free Cash Flow 375.65
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 37.10 19.95 2.02 284.31 34.11 / 77.70
BLISS GVS PHARMA LTD 122.65 16.07 1.27 1292.37 92.25 / 184.95
CIPLA LTD 1541.00 24.94 4.38 124457.39 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 272.25 22.56 2.76 801.26 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 37.10 22.35 6.30 284.31 34.11 / 77.70
AMRUTAJAN HEALTH LTD 679.10 39.81 6.59 1963.32 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8795.90 131.18 32.36 21989.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 122.65 15.93 1.26 1292.37 92.25 / 184.95

SAI LIFE SCIENCES LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
696.80 -2.44 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 702.10
  • 26 Days 710.20
  • 10 Days 705.40
  • 50 Days 711.80
  • 12 Days 706.50
  • 100 Days 710.90
  • 20 Days 709.40
  • 200 Days 710.90
707.42 PIVOT

First Support

688.83

First Resistance

732.88

Second Support

663.37

Second Resistance

751.47

Third Support

644.78

Third Resistance

776.93

RSI

50.77

ADX

16.96

MACD

-3.63

Williams % R

-49.84

Commodity Channel Index (CCI)

-21.28

Date

2025-04-29

Week

246956.00

Same Day

318493.00

Month

243230.00

1 Year

1.70

3 Year

1.70

Over 1 Month

-5.60%

down

Over 1 Year

0.00%

down

Over 3 Months

6.18%

down

Over 3 Years

0.00%

down

Over 6 Months

-6.58%

down

Over 5 Years

0.00%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

SAI LIFE SCIENCES LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
39.21%
Promoter Holdings
35.16%
FII
12.36%
DII
13.25%
Promoter Shares(Pledge Percentage)
2.67%
Name Shares Category
Tpg Asia Vii Sf Pte Ltd 5.1548272E7 (24.73%) Public Shareholding
Mytreyi Kanumuri Partner Of Marigold Partners (partnership Firm) 2.218555E7 (10.64%) Shareholding of Promoter and Promoter Group
Ranga Raju Kanumuri Partner Of Sunflower Partners (partnership Firm) 1.559357E7 (7.48%) Shareholding of Promoter and Promoter Group
Gokaraju Subba Raju 9634450.0 (4.62%) Shareholding of Promoter and Promoter Group
Mytreyi Kanumuri Partner Of Tulip Partners (partnership Firm) 9282060.0 (4.45%) Shareholding of Promoter and Promoter Group
Ranga Raju Kanumuri Partner Of Lily Partners (partnership Firm) 6900740.0 (3.31%) Shareholding of Promoter and Promoter Group
Invesco India Midcap Fund 6004357.0 (2.88%) Public Shareholding
Smallcap World Fund, Inc 5458706.0 (2.62%) Public Shareholding
Nippon Life India Trustee Ltd-a/c Nippon India Pha 5164027.0 (2.48%) Public Shareholding
Sai Quest Syn Private Limited 4591100.0 (2.2%) Shareholding of Promoter and Promoter Group
Hbm Private Equity India 4140124.0 (1.99%) Public Shareholding
Anitha Rudraraju Nandyala 3602370.0 (1.73%) Public Shareholding
Krishnam Raju Kanumuri 3008400.0 (1.44%) Shareholding of Promoter and Promoter Group
Goldman Sachs Funds - Goldman Sachs India Equity P 2769405.0 (1.33%) Public Shareholding
Mirae Asset Aggressive Hybrid Fund 2483554.0 (1.19%) Public Shareholding
Hsbc Aggressive Hybrid Fund 2344050.0 (1.12%) Public Shareholding
Raju Penmasta 2309800.0 (1.11%) Public Shareholding
Penmasta Aruna 2121220.0 (1.02%) Public Shareholding
Tanuja Gokaraju 1334535.0 (0.64%) Shareholding of Promoter and Promoter Group
Sudha Kanumuri 513160.0 (0.25%) Shareholding of Promoter and Promoter Group
Ranga Raju Kanumuri 169340.0 (0.08%) Shareholding of Promoter and Promoter Group
Mytreyi Kanumuri 61580.0 (0.03%) Shareholding of Promoter and Promoter Group
Continental Wines P Ltd 20190.0 (0.01%) Shareholding of Promoter and Promoter Group
Kanumuri Rangaraju Huf 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Kanumuri Bapi Raju Huf 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Gokaraju Venkata Sivarama Raju Huf 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sarada Gokaraju 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Kanumuri Anika 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Varun Kanumuri 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Akhil Kanumuri 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Kalidindi Bangarayamma 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Venkatasivarama Raju Gokaraju 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Prathima Kanumuri 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Kunaparaju Padmavathi 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Bapi Raju Kanumuri 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Tulip Family Trust 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Swathi Aqua Culture Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sunflower Family Trust 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sudarsan International 0.0 (0.0%) Shareholding of Promoter and Promoter Group
South India Research Institute Private 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Siris Impex 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Siris Herbex 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Siri Pharma 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sckrivets 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sai International 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Ranmyt Trading Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Prathima Aqua Culture Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Orchid Partners 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Orchid Family Trust 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Mytreyi Aqua Culture Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Marigold Family Trust 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Lily Family Trust 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Lakshmi Acqua Culture Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Jrv Properties Llp 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Hutansa 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Gokaraju Aqua Farms 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Chrysanthemum Partners 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Chrysanthemum Family Trust 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Chemrich Fine Chemicals Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

SAI LIFE SCIENCES LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

SAI LIFE SCIENCES LIMITED Share Price

Sai Life Sciences Limited was originally incorporated as Sai Dru Syn Laboratories Limited' as a Public Limited Company, dated January 25, 1999, issued by the Registrar of Companies, Andhra Pradesh at Hyderabad. The Company received the Certificate of Commencement of Business from Registrar of Companies, Andhra Pradesh on February 17, 1999. Subsequently, the Company name was changed from Sai Dru Syn Laboratories Limited' to Sai Life Sciences Limited' dated December 16, 2003.

Thereafter, the name of the Company was changed from Sai Life Sciences Limited' to Sai Advantium Pharma Limited' dated August 30, 2006 issued by the Registrar of Companies, Andhra Pradesh. Subsequently, the Company name was changed from Sai Advantium Pharma Limited' to Sai Life Sciences Limited' and a fresh Certificate of Incorporation dated May 28, 2012 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.

The Company is an innovator-focused contract research, development, and manufacturing organization (CRDMO). The Company provide end-to-end services across the drug discovery, development and manufacturing value chain, for small molecule NCE to global pharmaceutical innovators companies and biotechnology firms. It possess both (a) discovery / contract research and (b) CMC / CDMO capabilities.

Through the Scheme of Amalgamation, Prasad Drugs Limited was merged into the Company in 2004. The Company acquired Merrifield Pharma Private Limited in 2006. Later, the Company opened new areas of biology facility in Watertown (Greater Boston, MA) U.S.A. for innovative and creative small-molecule drugs in 2019. It launched Sai Nxt, an initiative to transform the organization into a new generation CDMO in 2020. It further added cellular analysis platforms at its discovery biology facility in Cambridge, Massachusetts, USA.

In 2021, the Company opened a new discovery biology facility at Unit II Plant in Hyderabad. In 2022, it opened the first set of new disconvery chemistry labs at Unit III Plant, Hyderabad.

In 2023, the Company opened high potency API manufacturing block at Unit IV Bidar Facility and has started API developability & formulations (D&F) capabilities at Unit II Hyderabad in 2024.

The Company is proposing to raise money from public through IPO by issue and allotment of 61,573,120 Equity Shares through Offer for Sale and a Fresh Issue aggregating to Rs 800 Crores Equity Shares.

Parent organization Indian Private
NSE symbol SAILIFE
Founded 1999
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Sai Life Sciences Ltd?

Answer Field

The share price of Sai Life Sciences Ltd for NSE is ₹ 696.8 and for BSE is ₹ 697.15.

What is the Market Cap of Sai Life Sciences Ltd?

Answer Field

The market cap of Sai Life Sciences Ltd for NSE is ₹ 12,30.76 Cr. and for BSE is ₹ 12,31.37 Cr. as of now.

What is the 52 Week High and Low of Sai Life Sciences Ltd?

Answer Field

The 52 Week High and Low of Sai Life Sciences Ltd for NSE is ₹ 808.80 and ₹ 636.10 and for BSE is ₹ 808.20 and ₹ 635.30.

How to Buy Sai Life Sciences Ltd share?

Answer Field

You can trade in Sai Life Sciences Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Sai Life Sciences Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the Current Share Price of Sai Life Sciences Ltd?

Answer Field

Sai Life Sciences Ltd share price is for NSE ₹ 696.8 & for BSE ₹ 697.15 as on Apr 30 2025 03:30 PM.

What is the Market Cap of Sai Life Sciences Ltd Share?

Answer Field

The market cap of Sai Life Sciences Ltd for NSE ₹ 12,30.76 & for BSE ₹ 12,31.37 as on Apr 30 2025 03:30 PM.

What is the P/E Ratio of Sai Life Sciences Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Sai Life Sciences Ltd share is 102.61.

What is the PB ratio of Sai Life Sciences Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Sai Life Sciences Ltd share is 94.14.

How to Buy Sai Life Sciences Ltd Share?

Answer Field

You can trade in Sai Life Sciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sai Life Sciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Sai Life Sciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sai Life Sciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|